MARINAKIS ANDREAS

CURRENT POSITION

Chief of the Hemodynamics Lab and Interventional Cardiology, 251 General Air Force Hospital

Head of the Hypertension Clinic, 251 General Air Force Hospital

Private Practice: 6 Trisi st, Chalandri

Memberships

1. Interventional Cardiology Working Group, and
2. ΕΑPCI (European Association of Percutaneous Cardiovascular Interventions)

EDUCATION & ACADEMIC TITLES

• Military School of Combat Support Officers (SSAS), School of Medicine Graduate (Degree Grade: EXCELLENT)
• Specialty training in Cardiology, University Department of Cardiology, “Ippokrateio” Hospital of Athens
• PhD awarded from the University of Athens - University Department of Cardiology - (Grade: EXCELLENT)
• Postgraduate Education: Gasthuisberg Hospital / Κathiolieke Universiteit Leuven (KUL)Belgium (48th World rank 2019) in INTERVENTIONAL CARDIOLOGY
• Attended special seminars and training courses on chronic total occlusion (CTO), rotational atherectomy (Vienna, Austria) and transcatheter aortic valve implantation -TAVI (Toulouse, France)
• Participation in conferences both domestically and abroad with papers and as a speaker
• Honorary distinction: 9th Panhellenic Congress of Arterial Hypertension 2005
  2nd Best Paper Award

PUBLICATIONS

International Medical Publications

1. Marinakis A. G, Vyssoulis G. P, Michaelides A. P, Karpanou E. A, Cokkinos D. V, Toutouzas P. K. Impact of abnormal nocturnal blood pressure fall on vascular function Αm J Hypertens 2003; 16:209-13
2. Vyssoulis G. P, Marinakis A.G, Karpanou E.A, Cokkinos D.V, Stefanadis C.I, Toutouzas P.K. The impact of 3rd generation β-blockers on endothelial function. Effect of smoking. Αm J Hypertens 2004; 17(7): 582-9
3. Lampropoulos KM, Marinakis A, Sokolis DP, Iliopoulos TA Evaluation of N-terminal prohormone B-type natriuretic Peptide in patients with acute coronary syndromes and percutaneous coronary intervention. .J Clin Hypertens Nov;12(11):861-8 (Impact Factor 2.23)
4. Marinakis A, Lampropoulos K, Iliopoulos T. Fracture of an atrial septal defect occluder as a cause of cardiac tamponade. Rev Esp Cardiol. 2010 Mar;63(3):346(Impact Factor 2.53)
5. Marinakis A, Lampropoulos K. . Precordial ST elevation due to isolated ventricular branch occlusion after stent implantation in the right coronary artery. Rev Esp Cardiol. 2009 Nov;62(11):1338-40(Impact Factor 2.53)
6. Marinakis A, Vydt T, Dens J, Gewillig M, Van Deyk K, Budts Percutaneous transcatheter ventricular septal defect closure in adults with Amplatzer septal occluders. . Acta Cardiol. 2007 Aug;62(4):391-5. (Impact Factor 0.63)
7. Aznaouridis KA, Vyssoulis GP, Karpanou EA, Marinakis AG, Barbetseas JD, Zervoudaki AI, Cokkinos DV, Stefanadis CI Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment..Blood Press Monit. 2007 Apr;12(2):87-94. (Impact Factor 1.52)
8. Vydt T, Marinakis A, Sinnaeve P, Dubois C, Desmet W Stents can jump! Int J Cardiol. 2007 Oct 31;122(1):93-5. Epub 2007 Jan 16. (Impact Factor 7.07)

Greek Medical Publications

1. Vyssoulis G.P., Marinakis A.G., Karpanou E.A., Barbetseas I.D., Rizos I.K, Toutouzas P.Κ. Mechanisms of action of dihydropyridines and cardiovascular risk Arterial Hypertension 8, 2-3: 144-149, 1999
2. Vyssoulis G.P., Marinakis A.G., Karpanou E.A., Barbetseas I.D., Rizos I.K, Toutouzas P.Κ. Microalbuminuria and albumin-creatinine quotient as indicators of left ventricular hypertrophy in non-diabetic hypertensive patients Arterial Hypertension 8, 2-3: 150-155, 1999.
3. Vyssoulis G.P., Marinakis A.G., Karpanou E.A., Barbetseas I.D., Rizos I.K, Toutouzas P.Κ. Favorable effects of nebivolol antihypertensive therapy on the thrombogenic system Arterial Hypertension 8, 2-3:156-163, 1999.
4. Vyssoulis G.P., Marinakis A.G., Karpanou E.A., Barbetseas I.D., Rizos I.K, Toutouzas P.Κ. Smoking worsens microalbuminuria in arterial hypertension. Arterial Hypertension 9, 1:40-45, 2000.
5. Vyssoulis G.P., Marinakis A.G., Karpanou E.A., Satvrotheodoros Ch.K., Barbetseas I.D., Rizos I.K, Toutouzas P.Κ. Aldosterone is a trophic factor in the development of left ventricular hypertrophy in arterial hypertension. Arterial Hypertension 9, 1: 46-51, 2000
6. Satvrotheodoros Ch.K., Vyssoulis G.P., Karpanou E.A., Arapogianni Α.Ν, Marinakis A.G., Toutouzas P.Κ. Regression of left ventricular hypertrophy following antihypertensive treatment with angiotensin converting enzyme inhibitors depends on its geometry. Arterial Hypertension 9,1:52-62, 2000
7. Marinakis A.G., Vyssoulis G.P., Karpanou E.A., Barbetseas I.D., Rizos I.K, Toutouzas P.Κ. Blood pressure and heart rate variability depending on the damages on the target-organs of arterial hypertension. Arterial Hypertension 11,1-3:90-95.2002
8. P. Kloufetos, Vyssoulis G.P., Karpanou E.A., Marinakis A.G., Satvrotheodoros Ch.K., Toutouzas P.Κ. Correlation of microalbuminuria and left ventricular hypertrophy with blood pressure components in hypertensive patients Arterial Hypertension 11,1-3:80-89.2002
9. Arapogianni Α.Ν, Vyssoulis G.P., Karpanou E.A., Marinakis A.G., Satvrotheodoros Ch.K., Toutouzas P.Κ. Hyperhomocysteinemia in elderly hypertensive patients. Arterial Hypertension 11,1-3:74-79.2002
10. Marinakis A.G., Vyssoulis G.P., Karpanou E.A., Aznaouridis Κ, Dimitrakopoulos S,, Toutouzas P.Κ. Increased incidence of cardiovascular risk factors and target-organ damage in hypertensive patients with α1-microglobulinuria. Arterial Hypertension 14,1:34-43, 2005
11. Gatzoulis Κ.Α, Marinakis A.G., Toutouzas P.Κ., Stefanadis Ch.I. Co-existence of ventricular block and persistent ventricular tachyarrhythmia in complicated myocardial infarction of the anterior wall. Is there hope? Heart & Vessels 1:20-27, 2004

CONTACT INFO

Telephone: +30 210 650 2000